Direct-to-Consumer Advertising of Prescription Drugs: The Evidence Says No

作者: Joel Lexchin , Barbara Mintzes

DOI: 10.1509/JPPM.21.2.194.17595

关键词:

摘要: Abstract There is little rationale for direct-to-consumer advertising of prescription drugs. Most new drugs offer if any therapeutic advantage over existing products. Direct-to-consumer advertisements frequently downplay safety information. Physicians are highly ambivalent about prescribing advertised requested by patients. no evidence that results in improvement health outcomes.

参考文章(35)
Richard L Kravitz, Michael S Wilkes, Robert A Bell, The educational value of consumer-targeted prescription drug print advertising. Journal of Family Practice. ,vol. 49, pp. 1092- 1098 ,(2000)
Richard L. Kravitz, Michael S. Wilkes, Robert A. Bell, Direct-to-consumer prescription drug advertising, 1989-1998. A content analysis of conditions, targets, inducements, and appeals. Journal of Family Practice. ,vol. 49, pp. 329- 329 ,(2000)
Anita Hardon, Elizabeth Hayes, Reproductive rights in practice: a feminist report on quality of care. Zed Books. ,(1997)
Margaret E. Ferry, Peter P. Lamy, Lome A. Becker, Physicians' knowledge of prescribing for the elderly. A study of primary care physicians in Pennsylvania. Journal of the American Geriatrics Society. ,vol. 33, pp. 616- 625 ,(1985) , 10.1111/J.1532-5415.1985.TB06318.X
Ajit M. Menon, Aparna D. Deshpande, Matthew Perri, George M. Zinkhan, Consumers'Attention to the Brief Summary in Print Direct-to-Consumer Advertisements: Perceived Usefulness in Patient–Physician Discussions: Journal of Public Policy & Marketing. ,vol. 22, pp. 181- 191 ,(2003) , 10.1509/JPPM.22.2.181.17636
Thomas Bodenheimer, Donald Drake, Marian Uhlman, Making Medicine, Making Money Journal of Public Health Policy. ,vol. 15, pp. 482- 484 ,(1994) , 10.2307/3343033
R W Spingarn, J A Berlin, B L Strom, When pharmaceutical manufacturers' employees present grand rounds, what do residents remember? Academic Medicine. ,vol. 71, pp. 86- 88 ,(1996) , 10.1097/00001888-199601000-00022
Alastair J. J. Wood, The Safety of New Medicines JAMA. ,vol. 281, pp. 1753- 1754 ,(1999) , 10.1001/JAMA.281.18.1753